TGF-β1 regulates the invasive and metastatic potential of mucoepidermoid carcinoma cells

Journal of Oral Pathology and Medicine

Volumn 40, Issue 10, 2011, Pages 762-768

  Wang, Jing ^a,b   Chen, Jian ^a   Zhang, Kailiang ^a   Zhao, Yuan ^a   Nör, Jacques E ^b,c,d   Wu, Junzheng ^e  

^a LANZHOU UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Extracellular matrix; Matrix metalloproteinase; Metastasis; Salivary gland cancer; Tumor progression

Indexed keywords

GELATINASE A; GELATINASE B; MATRIGEL; RNA; TRANSFORMING GROWTH FACTOR BETA1;

ADENOSQUAMOUS CARCINOMA; ANIMAL CELL; ARTICLE; ASSAY; BAGG ALBINO MOUSE; CANCER INVASION; CARCINOMA CELL; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; INOCULATION; LUNG METASTASIS; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CARCINOMA, MUCOEPIDERMOID; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; COLLAGEN; DISEASE PROGRESSION; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; GENETIC VECTORS; HUMANS; LAMININ; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PHENOTYPE; PROTEOGLYCANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SALIVARY GLAND NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80054099653     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2011.01051.x     Document Type: Article

References (24)

1. Kokemueller H, Swennen G, Brueggemann N, et al. Epithelial malignancies of the salivary glands: clinical experience of a single institution-a review. Int J Oral Maxillofac Surg 2004; 33: 423-32.
2. Guzzo M, Andreola S, Sirizzotti G, et al. Mucoepidermoid carcinoma of the salivary glands: clinicopathologic review of 108 patients treated at the National Cancer Institute of Milan. Ann Surg Oncol 2002; 9: 688-95.
3. Godkin JD, Dore JJ. Transforming growth factor beta and the endometrium. Rev Reprod 1998; 3: 1-6.
4. Roberts AB, Wakefield LM. The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 2003; 100: 8621-3.
5. Baritaki S, Sifakis S, Huerta-Yepez S, et al. Overexpression of VEGF and TGF-beta1 mRNA in Pap smears correlates with progression of cervical intraepithelial neoplasia to cancer: implication of YY1 in cervical tumorigenesis and HPV infection. Int J Oncol 2007; 31: 69-79.
6. Lu SL, Reh D, Li AG, et al. Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res 2004; 64: 4405-10.
7. Wang XJ. Role of TGF beta signaling in skin carcinogenesis. Microsc Res Tech 2001; 52: 420-9.
8. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29: 117-9.
9. Pasche B. Role of transforming growth factor beta in cancer. J Cell Physiol 2001; 186: 153-68.
10. Michl P, Ramjaun AR, Pardo OE, et al. CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell 2005; 7: 521-32.
11. Do TV, Kubba LA, Du H, et al. Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition. Mol Cancer Res 2008; 6: 695-705.
12. Lewis MP, Lygoe KA, Nystrom ML, et al. Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004; 90: 822-32.
13. Friese MA, Wischhusen J, Wick W, et al. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res 2004; 64: 7596-603.
14. Takayama S, Hatori M, Kurihara Y, et al. Inhibition of TGF-beta1 suppresses motility and invasiveness of oral squamous cell carcinoma cell lines via modulation of integrins and down-regulation of matrix-metalloproteinases. Oncol Rep 2009; 21: 205-10.
15. Jones E, Pu H, Kyprianou N. Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression. Expert Opin Ther Targets 2009; 13: 227-34.
16. Ganapathy V, Ge R, Grazioli A, et al. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis. Mol Cancer 2010; 9: 122-7.
17. Minamiya Y, Miura M, Hinai Y, et al. Transforming growth factor-β1 29T>C genetic polymorphism is associated with lymph node metastasis in patients with adenocarcinoma of the lung. Tumour Biol 2010; 31: 437-41.
18. Wang J, Wu JZ, Guo FP, et al. Expression of TGF-β1 in salivary gland mucoepidermoid carcinoma high and low metastatic cell lines. Stomatology 2006; 26: 87-90.
19. Yang HL, Wu JZ, Liu B, et al. Establishment and characterization of a metastatic cell line from spinal cord metastasis induced by injection of Mc3 cells in nude mice. J Pract Stomatol 2003; 19: 241-4.
20. Wang J, Wu JZ, Wei HY, et al. The effect of TGF-β1 gene silencing by shRNA on the proliferation of human mucoepidermoid salivary gland carcinoma Ms cells. Chinese J Clin Oncol 2007; 4: 18-21.
21. Li DQ, Wang ZB, Bai J, et al. Effects of mifepristone on invasive and metastatic potential of human gastric adenocarcinoma cell line MKN-45 in vitro and in vivo. World J Gastroenterol 2004; 10: 1726-9.
22. Lim S, Lee HY, Lee H. Inhibition of colonization and cell-matrix adhesion after nm23-H1 transfection of human prostate carcinoma cells. Cancer Lett 1998; 133: 143-9.
23. Zhang X, Liu Y, Gilcrease MZ, et al. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line. Cancer 2002; 95: 1663-72.
24. Sinpitaksakul SN, Pimkhaokham A, Sanchavanakit N, et al. Pavasant P.TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway. Biochem Biophys Res Commun 2008; 371: 713-8.